期刊文献+

星形孢菌素对前列腺癌细胞株PC-3增殖和凋亡的影响 被引量:1

Effects of staurosporine on the proliferation and apoptosis of prostate cancer PC-3 cells
下载PDF
导出
摘要 目的:探讨蛋白激酶C抑制剂星形孢菌素(ST)对前列腺癌细胞株PC-3增殖及凋亡的影响。方法:以ST(10-8mol/L)处理体外培养的PC-3细胞株。采用Western印迹检测细胞周期蛋白cyclin A、cyclin D1表达的变化。通过MTT实验、平板克隆实验检测ST对PC-3细胞增殖能力的影响。流式细胞仪检测各组细胞凋亡的情况。光镜观察细胞形态学的改变。结果:PC-3细胞经ST处理后cyclin A、cyclin D1蛋白表达明显降低。MTT实验结果显示ST对PC-3细胞的抑制作用自48 h后(19.35%)有显著性(F=31.06,P<0.01)。平板克隆实验结果显示组细胞克隆形成率ST组[(37.10±3.43)%]明显低于对照组((64.80±4.34)%,χ2=14.59,P<0.05]及DMSO组[(62.80±4.36)%,χ2=12.50,P<0.05]。流式细胞术结果显示ST组凋亡率(19.6±2.20)%与对照组(5.33±1.40)%和DMSO组(5.50±0.96)%比较显著增加(F=104.36,P<0.01)。光镜下可见:与对照组及DMSO组比较ST组细胞生长状态明显变差,细胞变圆,边缘模糊。结论:ST可以抑制前列腺癌细胞的生长和增殖,诱导细胞凋亡。 Objective: To investigate the effects of staurosporine(ST) on the proliferation and apoptosis of prostate cancer PC-3 cells.Methods: Prostate cancer PC-3 cells were treated in vitro with ST at 10-8mol/L.The expressions of cyclin A and cyclin D1 proteins in the cells were detected by Western blot,the effect of ST on the proliferation of the cells determined by MTT assay and plate colony formation,the apoptosis of the cells examined by flow cytometry,and their morphological changes observed under the light microscope.Results: ST treatment markedly decreased the expressions of cyclin A and cyclin D1 in the PC-3 cells,and significantly inhibited the growth of the PC-3 cells(19.35%) at 48 h.(F = 31.06,P 0.01).The colony formation rate of the PC-3 cells was(37.10 ± 3.43) % in the ST group,significantly lower than(64.80 ± 4.34) % in the control(χ2 = 14.59,P 0.05) and(62.80 ± 4.36) % in the DMSO group(χ2 =12.50,P 0.05),while the apoptosis rate of the cells was remarkably higher in the ST group([19.6 ± 2.20] %) than in the control([5.33 ± 1.40] %) and the DMSO group([5.50 ± 0.96] %)(F = 104.36,P 0.01).Under the light microscope,the ST-treated cells were round with indistinct margins as compared with those of the other two groups.Conclusion: ST could significantly inhibit the proliferation and induce the apoptosis of PC-3 cells.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2011年第10期884-887,共4页 National Journal of Andrology
关键词 前列腺癌 增殖 凋亡 蛋白激酶C抑制剂 星形孢菌素 prostate cancer proliferation apoptosis protein kinase C inhibitor staurosporine
  • 相关文献

参考文献8

二级参考文献41

  • 1He SW,Shen KQ,He YJ,Xie B,Zhao YM.Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma[J].World Journal of Gastroenterology,1999,5(5):408-416. 被引量:20
  • 2孙祥宙,邓春华,郭海彬,刘建中.成人睾丸间质细胞的培养和鉴定[J].中华男科学杂志,2005,11(5):356-358. 被引量:15
  • 3朱刚,刘明,万奔.早期前列腺癌的诊断与治疗[J].中华男科学杂志,2005,11(9):693-696. 被引量:31
  • 4Stephenson RA, Stanford JL. Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen. World J Urol, 1997, 15 (6) :331-335.
  • 5Rajbabu K, Chandrasekera S, Zhu G, et al. Racial origin is associated with poor awareness of prostate cancer in UK men, but can be increased by simple information. Prostate Cancer Prostatic Dis, 2007, 10(3):256-260.
  • 6Steele CB, Miller DS, Maylahn C, et al. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health, 2000, 90(10) :1595-1600.
  • 7Jones AR, Shipp M, Thompson CJ, et al. Prostate cancer knowledge and beliefs among Black and White older men in rural and urban counties. J Cancer Educ, 2005, 20(2) :96-102.
  • 8Nikula H, Huhtaniemi I. Gonadotropin-releasing hormone agonist activates protein kinase C in rat Leydig cells. Mol Cell Endocrinol, 1988, 55(1): 53-59.
  • 9Kim KY, Choi KC, Park SH, et al. Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells. J Clin Endocrinol Metab, 2004, 89(6) : 3020-3026.
  • 10Svechnikov K, Stocco DM, SOder O. Interleukin-lalpha stimulates stereidogenic acute regulatory protein expression via p38 MAP kinase in iwanature rat Leydig cells. J Mol Endocrinol, 2003, 30(1) : 59-67.

共引文献16

同被引文献17

  • 1Shariat SF, Seherr DS, Gupta A, et al. Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis. Arch Esp Urol, 2011, 64(8): 681-694.
  • 2Raziuddin A, Court D, Sarkar FH, et al. A c-erbB-2 promoter-specific nuclear matrix protein from human tumor tissues meiates NF-KappaB DNA binding activity. J Biol Chem, 1997, 272 (25) : 15715-15720.
  • 3Cazares LH, Drake RR, Esquela-Kirscher A, et al. Molecular pathology of prostate cancer. Cancer Biomark, 2011, 9 ( 1-6 ): 441-459.
  • 4Tosoian J, Loeb S. PSA and beyond : The past, present, and future of investigative biomarkers for prostate cancer. Scientific World Journal, 2010, 10: 1919-1931.
  • 5Stamey TA. Preoperation serum prostate-specific antigen (PSA) below 10 μg/L predicats neither the presence of prostate cancer nor the rate of post operation PSA failure. Clin Chem, 2001,47 (4) : 631-634.
  • 6Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate specific antigen level < or = 4.0 ng/ml per milliliter. N Engl J Med, 2004, 350 (22): 2239-2246.
  • 7Kumar A, Kumar R, Gupta NP. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Jpn J Clin Oncol, 2006, 36(3) : 172-175.
  • 8Lau P, Chin JL, Pautler S, et al. NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients. Can Urol Assoe J, 2009, 3(6) : 454-458.
  • 9Inoue T, Leman ES, Yeater DB, et al. The potential role of purine-rich element binding protein (PUR) alpha as a novel treat- ment target for hormone-refractory prostate cancer. Prostate, 2008, 68(10) : 1048-1056.
  • 10Leman ES, Madigan MC, Brunagel G, et al. Nuclear matrix localization of high mobility group protein I ( Y ) in a transgenic mouse model for prostate cancer. J Cell Biochem, 2003, 88 (3) : 599-608.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部